UK approves new Sotrovimab drug that could work against Omicron; "good news" emerges in early data on new variant; nothing to stop festive parties and no guidance on who you should kiss at Christmas, according to UK government.
According
to report, the UK has approved another antibody treatment for people with Covid
that cuts the risk of severe illness.
It's
called sotrovimab, and scientists say preliminary checks suggest it should work
well even against new variants such as Omicron.
The drug,
given in a drip into a vein, binds to the virus to stop it entering our cells.
In a
clinical trial, a single dose reduced the risk of hospitalisation and death by
79% in high risk adults.
It is the
second drug of its kind - a monoclonal antibody treatment - that UK regulators
have approved.
No comments:
Post a Comment